Kodera Yasuhiro
Department of Surgery II (Department of Gastroenterological Surgery), Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya J Med Sci. 2013 Feb;75(1-2):3-10.
Peritoneal metastasis from gastric cancer is often undetectable by routine imaging studies. Even a microscopic metastasis detected only by cytologic examination of the peritoneal washes denotes a dismal prognosis, and surgery is ruled out as futile for patients who turn out to be cytology-positive by staging laparoscopy. On the other hand, recent developments in cancer chemotherapy have improved the outcome of the cytology-positive population to the point where a certain proportion of these patients survive for 5 years through a straightforward strategy of radical surgery followed by chemotherapy. Thus, there is certainly a role for surgeons in patients with minimal peritoneal metastasis, both in clinical practice and in clinical trials where multimodal treatment strategies including surgery are to be explored. Even in this category of patients, surgery in combination with various types of chemotherapy remains the only hope for a cure.
胃癌的腹膜转移通常无法通过常规影像学检查发现。即使是仅通过腹膜灌洗的细胞学检查检测到的微小转移也预示着预后不良,对于经分期腹腔镜检查显示细胞学阳性的患者,手术被认为是徒劳而被排除。另一方面,癌症化疗的最新进展改善了细胞学阳性人群的治疗结果,以至于通过直接的根治性手术加化疗策略,这些患者中有一定比例能够存活5年。因此,对于腹膜转移极少的患者,外科医生在临床实践以及探索包括手术在内的多模式治疗策略的临床试验中肯定都能发挥作用。即使在这类患者中,手术联合各种化疗仍然是治愈的唯一希望。